Literature DB >> 30939502

Acute Inflammation in Traumatic Brain Injury and Polytrauma Patients Using Network Analysis.

Bradley Rowland1, Jude P J Savarraj2, Jay Karri1, Xu Zhang1, Jessica Cardenas1, H Alex Choi2, John B Holcomb1, Charles E Wade1.   

Abstract

INTRODUCTION: Traumatic brain injury (TBI) is associated with secondary injury to the central nervous system (CNS) via inflammatory mechanisms. The combination of polytrauma and TBI further exacerbates the inflammatory response to injury; however, combined injury phenomena have not been thoroughly studied. In this study, we examined the inflammatory differences between patients with TBI versus patients with polytrauma, but no TBI (polytrauma). We hypothesize that patients with TBI have a heightened early inflammatory response compared with polytrauma.
METHODS: We conducted a single-center retrospective study of a cohort of patients with polytrauma, who were enrolled in the PROPPR study. These patients had blood samples prospectively collected at eight time points in the first 3 days of admission. Using radiological data to determine TBI, our polytrauma cohort was dichotomized into TBI (n = 30) or polytrauma (n = 54). Inflammatory biomarkers were measured using ELISA. Data across time were compared for TBI versus polytrauma groups using Wilcoxon rank-sum test. Network analysis techniques were used to systematically characterize the inflammatory responses at admission.
RESULTS: Patients with TBI (51.6%) had a higher 30-day mortality compared with polytrauma (16.9%) (P <0.001). Expression levels of IL6, IL8, and CCL2 were elevated from the 2-h through 24-h time points, becoming significant at the 6-h time point (IL6, IL8, and CCL2; P <0.05) (). CSF3 showed a similar pattern, but did not attain significance. TBI and polytrauma networks underwent diverging trends from admission to the 6-h time point.
CONCLUSION: Patients with TBI demonstrated upregulations in proinflammatory cytokines IL6, IL8, and CCL2. Utilizing informatics methods, we were able to identify temporal differences in network trends, as well as uncharacterized cytokines and chemokines in TBI. These data suggest TBI induces a distinct inflammatory response and pathologically heightened inflammatory response in the presence of polytrauma and may propagate worsened patient outcomes including mortality.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 30939502      PMCID: PMC6765456          DOI: 10.1097/SHK.0000000000001349

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.533


  48 in total

1.  Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.

Authors:  John B Holcomb; Barbara C Tilley; Sarah Baraniuk; Erin E Fox; Charles E Wade; Jeanette M Podbielski; Deborah J del Junco; Karen J Brasel; Eileen M Bulger; Rachael A Callcut; Mitchell Jay Cohen; Bryan A Cotton; Timothy C Fabian; Kenji Inaba; Jeffrey D Kerby; Peter Muskat; Terence O'Keeffe; Sandro Rizoli; Bryce R H Robinson; Thomas M Scalea; Martin A Schreiber; Deborah M Stein; Jordan A Weinberg; Jeannie L Callum; John R Hess; Nena Matijevic; Christopher N Miller; Jean-Francois Pittet; David B Hoyt; Gail D Pearson; Brian Leroux; Gerald van Belle
Journal:  JAMA       Date:  2015-02-03       Impact factor: 56.272

Review 2.  Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.

Authors:  Jenna M Ziebell; Maria Cristina Morganti-Kossmann
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

3.  Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury.

Authors:  Luiz Carlos Brasiliano Ferreira; Andrea Regner; Karen Dal Lago Miotto; Silvana de Moura; Nilo Ikuta; Andréia Escosteguy Vargas; José Artur Bogo Chies; Daniel Simon
Journal:  Brain Inj       Date:  2014-05-15       Impact factor: 2.311

4.  Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure.

Authors:  R M Roumen; T Hendriks; J van der Ven-Jongekrijg; G A Nieuwenhuijzen; R W Sauerwein; J W van der Meer; R J Goris
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

Review 5.  Insights into the Role of Chemokines, Damage-Associated Molecular Patterns, and Lymphocyte-Derived Mediators from Computational Models of Trauma-Induced Inflammation.

Authors:  Rami A Namas; Qi Mi; Rajaie Namas; Khalid Almahmoud; Akram M Zaaqoq; Othman Abdul-Malak; Nabil Azhar; Judy Day; Andrew Abboud; Ruben Zamora; Timothy R Billiar; Yoram Vodovotz
Journal:  Antioxid Redox Signal       Date:  2015-12-10       Impact factor: 8.401

Review 6.  Postinjury multiple organ failure.

Authors:  David Dewar; Frederick A Moore; Ernest E Moore; Zsolt Balogh
Journal:  Injury       Date:  2009-06-21       Impact factor: 2.586

Review 7.  Clinical evidence of inflammation driving secondary brain injury: a systematic review.

Authors:  Holly E Hinson; Susan Rowell; Martin Schreiber
Journal:  J Trauma Acute Care Surg       Date:  2015-01       Impact factor: 3.313

8.  Peripheral Inflammatory Markers and Antioxidant Response during the Post-Acute and Chronic Phase after Severe Traumatic Brain Injury.

Authors:  Federico Licastro; Silvana Hrelia; Elisa Porcellini; Marco Malaguti; Cristina Di Stefano; Cristina Angeloni; Ilaria Carbone; Laura Simoncini; Roberto Piperno
Journal:  Front Neurol       Date:  2016-11-02       Impact factor: 4.003

Review 9.  Monitoring the Neuroinflammatory Response Following Acute Brain Injury.

Authors:  Eric Peter Thelin; Tamara Tajsic; Frederick Adam Zeiler; David K Menon; Peter J A Hutchinson; Keri L H Carpenter; Maria Cristina Morganti-Kossmann; Adel Helmy
Journal:  Front Neurol       Date:  2017-07-20       Impact factor: 4.003

Review 10.  Changing patterns in the epidemiology of traumatic brain injury.

Authors:  Bob Roozenbeek; Andrew I R Maas; David K Menon
Journal:  Nat Rev Neurol       Date:  2013-02-26       Impact factor: 42.937

View more
  4 in total

1.  Multiplex Assessment of Serum Chemokines CCL2, CCL5, CXCL1, CXCL10, and CXCL13 Following Traumatic Brain Injury.

Authors:  Yuwen Chen; Ying Wang; Jian Xu; Tingting Hou; Jing Zhu; Yingzi Jiang; Liying Sun; Chunling Huang; Lulu Sun; Su Liu
Journal:  Inflammation       Date:  2022-08-15       Impact factor: 4.657

2.  Mast Cell Activation, Neuroinflammation, and Tight Junction Protein Derangement in Acute Traumatic Brain Injury.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Sudhanshu P Raikwar; Smita A Zaheer; Shankar S Iyer; Casey Burton; Donald James; Asgar Zaheer
Journal:  Mediators Inflamm       Date:  2020-06-24       Impact factor: 4.711

Review 3.  Neuro-Inflammation in Pediatric Traumatic Brain Injury-from Mechanisms to Inflammatory Networks.

Authors:  Erik Fraunberger; Michael J Esser
Journal:  Brain Sci       Date:  2019-11-09

4.  Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury.

Authors:  Adel Helmy; Eric Peter Thelin; Philipp Lassarén; Caroline Lindblad; Arvid Frostell; Keri L H Carpenter; Mathew R Guilfoyle; Peter J A Hutchinson
Journal:  J Neuroinflammation       Date:  2021-09-25       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.